Weaver Consulting Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Weaver Consulting Group's AMGN Position: Q1 2026 in Review
Weaver Consulting Group reduced its Amgen (AMGN) stake by 2.7% in Q1 2026, selling an estimated $17.5K and leaving 1,750 shares worth $616K. The position accounts for 0.15% of the portfolio, ranked #121.
Weaver Consulting Group first reported a position in AMGN in Q1 2019 and has held it in 29 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Weaver Consulting Group held 1,750 shares of Amgen worth $616K as of Q1 2026.
- Weaver Consulting Group sold 49 Amgen shares in Q1 2026, an estimated $17.5K.
- Amgen made up 0.15% of Weaver Consulting Group's portfolio in Q1 2026, its #121 holding.
- Weaver Consulting Group first reported a position in Amgen in Q1 2019 and has held it in 29 quarters since.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Weaver Consulting Group's 13F filing for Q1 2026, filed 15 May 2026.